Compare Cronos Group Inc (CRON) vs Rex Fang & Innovation Equity Premium Income ETF (FEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? Cronos Group Inc trades at $2.75 (market cap $1.02B), while Rex Fang & Innovation Equity Premium Income ETF trades at $42.14. The key difference: Cronos Group Inc is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| CRON | FEPI | |
|---|---|---|
Market Cap | $1.02B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $3.27 | $49.54 |
52-Week Low | $1.95 | $38.13 |
Enterprise Value | $203.29M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $41.98, down 1.65% with a bearish technical signal. The ETF employs an aggressive covered call strategy on concentrated AI and mega-cap tech holdings, generating weekly dividends averaging $0.21-0.22 recently. Technical indicators show bearish momentum with resistance at $43 and support at $42, while oscillators remain neutral. The fund's 25% yield attracts retail investors but comes with NAV erosion concerns during market downturns.
FEPI offers high income potential but faces structural limitations from its covered call strategy that caps upside during tech rallies. The concentrated portfolio of high-beta names amplifies downside risk, making it suitable for income-focused investors willing to accept limited capital appreciation. Recent transition to weekly distributions enhances compounding but doesn't address fundamental NAV erosion risks in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →
